Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Potassium channel subfamily K member 9 (TASK-3) is a pH-sensitive, two-pore domain potassium (K2P) channel that plays a vital role in setting the resting membrane potential and controlling neuronal excitability (UniProt Q9NPC2). It is highly expressed in the central nervous system, particularly within the brainstem's serotonergic neurons of the dorsal raphe nucleus, where it modulates the firing patterns of these cells (PMID: 10801917). TASK-3 channels are sensitive to extracellular acidification, which leads to channel closure and subsequent neuronal depolarization (PMID: 21123634). This mechanism is crucial for physiological processes such as the respiratory response to CO2 and the regulation of sleep-wake cycles. Pathologically, mutations in the KCNK9 gene cause Birk-Barel syndrome, a genomic imprinting disorder, and the channel is frequently overexpressed in various malignancies, promoting tumor cell survival and proliferation (PMID: 25635015). Therapeutic strategies targeting TASK-3 include small-molecule inhibitors like doxapram for respiratory disorders and potential activators for neuroprotection. Because of its role in serotonergic signaling, it is also a target of interest for treating mood disorders and sleep-related breathing issues.
Modulation of background potassium leak current to regulate membrane potential and cellular excitability.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium channel subfamily K member 9 (KCNK9) (TASK-3).